Korea emerging as global drug trial hub

Published: 2012-09-25 06:59:00

Updated: 2012-09-25 06:59:00

Korea is rapidly emerging as a global hub of clinical trials for multinational pharmaceutical companies thanks to its excellent infrastructure for clinical research, Kim Jon-ran, Vice President of ICON plc, said in a recent interview with Yakup Shinmoon.

“These clinical trials provide enormous...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK